Best of Rheumatoid Arthritis (RA) Forum
WebcastFaculty
OVERVIEW
Best of Rheumatoid Arthritis (RA) Forum is organized by Vindico Medical Education and will be held during Sep 09, 2016 - Sep 08, 2018.
The target audience for this medical event is rheumatologists and other health care professionals involved in the treatment of patients with rheumatoid arthritis (RA). This CME Conference has been approved for a maximum of 2.0 AMA PRA Category 1 Credits.
Conference Objectives are :
Upon successful completion of this educational activity, participants should be better able to:
• Describe the underlying principles of innate and adaptive immunity as they contribute to understanding the mechanism of action of existing and developing immune-based therapies including anti-cytokine therapies (TNF, IL-6, IL-17, and others); T-cell- and B-cell-directed therapies; anti-checkpoint-based therapies; small molecules; anti-sense therapies; immunoregulatory-based therapies; and others.
• Examine the underlying principles of innate and adaptive immunity as they contribute to the pathophysiologic basis of autoimmune and autoinflammatory diseases like RA.
• Explain the clinical and immunologic progression of RA from asymptomatic autoimmunity to pre-RA and RA and relate the role of anti-citrullinated protein antibodies (ACPAs) and gene interactions to this process.
• Describe recent advances in innate and adaptive immunity that contribute to the understanding of immunopathogenesis, immunodiagnostics, and selection of immune-based therapies including:
? Genetics and epigenetics in the immunopathogenesis in autoimmune and autoinflammatory diseases.
? The microbiome and microbiome and their relationship to the integrated immune response and immunopathogenesis.
? The concept of immunologic checkpoint-directed therapies as a basis for cancer treatment and autoimmune and autoinflammatory complications relevant to rheumatologists.
Additional details will be posted as soon as they are available.
The target audience for this medical event is rheumatologists and other health care professionals involved in the treatment of patients with rheumatoid arthritis (RA). This CME Conference has been approved for a maximum of 2.0 AMA PRA Category 1 Credits.
Conference Objectives are :
Upon successful completion of this educational activity, participants should be better able to:
• Describe the underlying principles of innate and adaptive immunity as they contribute to understanding the mechanism of action of existing and developing immune-based therapies including anti-cytokine therapies (TNF, IL-6, IL-17, and others); T-cell- and B-cell-directed therapies; anti-checkpoint-based therapies; small molecules; anti-sense therapies; immunoregulatory-based therapies; and others.
• Examine the underlying principles of innate and adaptive immunity as they contribute to the pathophysiologic basis of autoimmune and autoinflammatory diseases like RA.
• Explain the clinical and immunologic progression of RA from asymptomatic autoimmunity to pre-RA and RA and relate the role of anti-citrullinated protein antibodies (ACPAs) and gene interactions to this process.
• Describe recent advances in innate and adaptive immunity that contribute to the understanding of immunopathogenesis, immunodiagnostics, and selection of immune-based therapies including:
? Genetics and epigenetics in the immunopathogenesis in autoimmune and autoinflammatory diseases.
? The microbiome and microbiome and their relationship to the integrated immune response and immunopathogenesis.
? The concept of immunologic checkpoint-directed therapies as a basis for cancer treatment and autoimmune and autoinflammatory complications relevant to rheumatologists.
Additional details will be posted as soon as they are available.
SPECIALITIES
RheumatologyRELATED ONLINE COURSES
Quick Links